Skip to main content

Table 3 Summary of the worst-case target coverage as percentage of prescription dose

From: A single-field integrated boost treatment planning technique for spot scanning proton therapy

  SFUD% (range) SFIB% (range) IMPT% (range)
D 95 /D pre (All patients) 102.7 ± 5.0 100 ± 1.3 -
(97.6-115.9) (97.6-102.5) -
D 98 /D pre (All patients) 101.1 ± 5.2 98.1 ± 2.1 -
(95.2-114.2) (95.0-101.2) -
EUD/D pre (All patients) 108.0 ± 6.1 104.6 ± 2.8 -
(101.6-120.2) (101.9-108.9) -
D 95 /D pre (exclude patient 2) 103.8 ± 5.5 100.1 ± 1.5 97.4 ± 3.3
(99.7-115.9) (97.6-102.5) (92.7-101.9)
D 98 /D pre (exclude patient 2) 101.9 ± 5.9 97.9 ± 2.4 93.6 ± 6.1
(95.2-114.2) (95.0-101.2) (82.4-100.4)
EUD/D pre (exclude patient 2) 109.5 ± 6.7 105.5 ± 3.0 102.3 ± 4.1
(101.6-120.2) (101.9-108.9) (95.4-106.8)
  1. Abbreviations: D 95 and D 98 , doses to 95% and 98% of the target volumes as displayed on the cumulative DVH, respectively, D pre , prescription dose, EUD equivalent uniform dose, SFUD single field uniform dose, SFIB single-field integrated boost, IMPT intensity modulated proton therapy.